A carregar...
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
BACKGROUND: We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma. DESIGN AND METHODS: Ninety-four young patients (age, 18–60) with stage III–IV diffuse larg...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Ferrata Storti Foundation
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2738717/ https://ncbi.nlm.nih.gov/pubmed/19586937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.007005 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|